While it appears simple, dental billing can be a daunting task. The billing team needs to always be aware of all developments and changes in regulatory guidelines, CDT codes, etc. This helps the team to ensure accurate billing and faster reimbursements.
One rule that the dental team needs to be aware of is the use of antimicrobial agents that come under code D4381. The team must have a thorough understanding of the precise usage of D4381 for controlled-release antimicrobial therapy.
In terms of application, it implies utilising special antimicrobial medication in gum pockets affected by a bacterial infection. In such situations, the team needs to grasp billing guidelines and documentation obligations completely. This helps ensure effective use of the patient’s insurance policy.
One needs to confirm if such a benefit is part of the insurance plan, as not all plans might offer coverage. The team might have to provide periodontal charting indicating pockets of at least 5mm. Moreover, if the claim is submitted with a nonqualifying scaling and root planing (SRP), then the claim will be rejected as SRP has been denied.
The dental code D4381 refers to a specific placement of an antimicrobial solution using a controlled-release system. This is applied directly to the affected gum tissue around an individual tooth.
This code will generally be used for the treatment of a gum disease that needs supplementary intervention of an antimicrobial agent. The practice can ideally use the D4381 when dental practitioners directly insert specialised antimicrobial agents, such as doxycycline gel or chlorhexidine chips, into the patient’s gum pocket.
The D4391 code cannot be used to cover oral antibiotics or standard irrigation procedures. Unsuitable application of the code can lead to a claim denial. The dental team needs to confirm that the gum condition and treatment history support the use of this code.
There are certain constraints and clarifications regarding code D4381 as follows that need to be noted:
The CDT code D4381 was revised some years back, and recent updates confirm that the code is applicable per tooth, not per site. The code must be used only for a localised delivery. It cannot be used for a full-mouth procedure.
The procedure conducted must be accurately documented and captured as per the nomenclature of the code. The description or nomenclature clearly suggests a localised delivery of antimicrobial agents by using a controlled release vehicle. The delivery needs to happen to a diseased tooth.
The dental practice can make use of any FDA-approved subgingival delivery device. These devices need to contain antimicrobial products that are directly inserted into periodontal pockets to overcome bacterial infections.
The slow release of such antimicrobial agents directly into the affected tooth ensures that they stay at the site to effectively act over an adequate period. This helps to reduce bacterial infection and gum inflammation.
As with all claim submissions, clinical documentation is vital for a claim to get approved and processed for reimbursement to the dental practice. While submitting a claim under code D4381, the claim must include the tooth number treated, the site or sites where the antimicrobial products were directly released, and the reasons for placement of the same.
The team also needs to attach all documents that prove the medical necessity of such a recommendation made by the dental practice. These could include radiographs, clinical notes, periodontal charting, and probing, etc.
There are some policies that can be applicable to a pharmaceutical company that manufactures antimicrobial agents and has a pharmacy program. The insurance company offering coverage to a patient can collaborate with the pharmaceutical company by using the patient’s pharmacy plan.
The pharma company can bill the medicament directly to the insurance firm while delivering the medicament to the dental practice. This can be beneficial to a dental practice as it doesn’t need to buy any medications and avoids any storage challenges or expiry of medications while at the practice.
The practice charges a fee for placement of the antimicrobial agents directly at the sites as per the needs of the patient. This includes the cost of the medication as well as the service and consulting fee.
When the billing for the medicament is done directly to the insurance company based on the patient’s pharmacy benefit plan, the dental team can still use D4381 as the appropriate code for billing. The practice might have to charge a lower fee since the medication has been directly billed to the insurance firm.
The dental practice team needs to adhere to all CDT codes and guidelines, and hence, the team needs to be periodically trained on billing protocols and documentation.
While using code D4381, documentation will play a crucial role. The dental team needs to ensure a few points while filing for a claim:
For a claim to be successful, a few approaches that can be considered are:
The dental team must have a complete understanding of the usage of D4381 for controlled-release antimicrobial therapy. Clinical notes & explanations, documentation, proper usage of codes, and precise claim preparations can help to garner prompt D4381 reimbursement.
Capline Dental is a leading provider of end-to-end services to dental practices of all sizes in the USA and can be reached at info@caplinedentalservices.com
